AARD

Aardvark Therapeutics

• PR Newswire·4d ago

  Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate- HBSS

• PR Newswire·05/19 16:30

  Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate- Hagens Berman

• Seeking Alpha·05/18 15:59

  Aardvark Therapeutics: Regulatory Uncertainty Clouds ARD-101 Path Forward

• TipRanks·05/17 21:06

  FDA Clinical Hold, Competitive Pressure Drive Aardvark Therapeutics Downgrade as Price Target Slashed from $18 to $4

• TipRanks·05/15 20:00

  Aardvark Therapeutics downgraded to Underperform from Buy at BofA

• Seeking Alpha·05/15 18:28

  Aardvark plummets on FDA clinical hold on Prader-Willi Syndrome asset

• Reuters·05/15 17:46

  BUZZ-U.S. STOCKS ON THE MOVE-Intel, Nvidia, Aardvark

• Dow Jones·05/15 17:13

  Aardvark Therapeutics Is Maintained at Buy by B. Riley Securities

• Dow Jones·05/15 17:13

  Aardvark Therapeutics Price Target Cut to $7.00/Share From $8.00 by B. Riley Securities

• Benzinga·05/15 17:06

  12 Health Care Stocks Moving In Friday's Intraday Session

• Benzinga·05/15 17:03

  B. Riley Securities Maintains Buy on Aardvark Therapeutics, Lowers Price Target to $7

• Benzinga·05/15 15:49

  This Unity Bancorp Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

• Reuters·05/15 15:47

  BUZZ-Aardvark slumps after FDA puts clinical hold on rare disease drug

• TipRanks·05/15 15:16

  Aardvark Therapeutics price target lowered to $7 from $8 at B. Riley

• Dow Jones·05/15 14:52

  Aardvark Therapeutics Cut to Neutral From Buy by BTIG